全文获取类型
收费全文 | 189131篇 |
免费 | 56066篇 |
国内免费 | 7650篇 |
专业分类
耳鼻咽喉 | 2654篇 |
儿科学 | 6239篇 |
妇产科学 | 1656篇 |
基础医学 | 25627篇 |
口腔科学 | 6805篇 |
临床医学 | 28396篇 |
内科学 | 35380篇 |
皮肤病学 | 8774篇 |
神经病学 | 17256篇 |
特种医学 | 6120篇 |
外国民族医学 | 29篇 |
外科学 | 22163篇 |
综合类 | 27313篇 |
现状与发展 | 33篇 |
一般理论 | 27篇 |
预防医学 | 15424篇 |
眼科学 | 3990篇 |
药学 | 19523篇 |
199篇 | |
中国医学 | 10925篇 |
肿瘤学 | 14314篇 |
出版年
2024年 | 331篇 |
2023年 | 1774篇 |
2022年 | 3711篇 |
2021年 | 7265篇 |
2020年 | 9854篇 |
2019年 | 14181篇 |
2018年 | 13674篇 |
2017年 | 15311篇 |
2016年 | 15404篇 |
2015年 | 17249篇 |
2014年 | 18567篇 |
2013年 | 19638篇 |
2012年 | 14465篇 |
2011年 | 15078篇 |
2010年 | 17200篇 |
2009年 | 12280篇 |
2008年 | 9773篇 |
2007年 | 8332篇 |
2006年 | 7635篇 |
2005年 | 6237篇 |
2004年 | 4672篇 |
2003年 | 4481篇 |
2002年 | 3786篇 |
2001年 | 3160篇 |
2000年 | 2540篇 |
1999年 | 1579篇 |
1998年 | 704篇 |
1997年 | 701篇 |
1996年 | 567篇 |
1995年 | 489篇 |
1994年 | 464篇 |
1993年 | 284篇 |
1992年 | 241篇 |
1991年 | 232篇 |
1990年 | 192篇 |
1989年 | 175篇 |
1988年 | 147篇 |
1987年 | 117篇 |
1986年 | 100篇 |
1985年 | 78篇 |
1984年 | 51篇 |
1983年 | 14篇 |
1982年 | 18篇 |
1981年 | 25篇 |
1980年 | 10篇 |
1979年 | 17篇 |
1977年 | 7篇 |
1972年 | 6篇 |
1971年 | 6篇 |
1966年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 61 毫秒
101.
2017年12月至2018年12月,在天津医科大学总医院健康管理中心定期健康体检的3 509名研究对象中,曾罹患肿瘤、罹患慢病和健康对照三组分别有399、1 555、1 555名。年龄为(55.87±11.98)岁,男性占31.38%。慢病组MS患病率(42.44%)高于曾罹患肿瘤组(34.59%)和健康对照组(18.65%)( P<0.001)。与健康对照组相比,曾罹患肿瘤组和慢病组MS患病风险 OR(95% CI)值分别为2.13(1.61~2.83)和2.85(2.23~3.66);曾罹患乳腺癌和甲状腺癌MS患病风险 OR(95% CI)值分别为3.56(2.04~6.21)和2.77(1.46~5.25)。 相似文献
102.
103.
Enrique Luengo Izaskun Buendia Cristina Fernndez‐Mendívil Paula Trigo‐Alonso Pilar Negredo Patrycja Michalska Borja Hernndez‐García Cristina Snchez‐Ramos Juan A. Bernal Tsuneya Ikezu Rafael Len Manuela G. Lpez 《Journal of pineal research》2019,67(1)
Alterations in autophagy are increasingly being recognized in the pathogenesis of proteinopathies like Alzheimer's disease (AD). This study was conducted to evaluate whether melatonin treatment could provide beneficial effects in an Alzheimer model related to tauopathy by improving the autophagic flux and, thereby, prevent cognitive decline. The injection of AAV‐hTauP301L viral vectors and treatment/injection with okadaic acid were used to achieve mouse and human ex vivo, and in vivo tau‐related models. Melatonin (10 μmol/L) impeded oxidative stress, tau hyperphosphorylation, and cell death by restoring autophagy flux in the ex vivo models. In the in vivo studies, intracerebroventricular injection of AAV‐hTauP301L increased oxidative stress, neuroinflammation, and tau hyperphosphorylation in the hippocampus 7 days after the injection, without inducing cognitive impairment; however, when animals were maintained for 28 days, cognitive decline was apparent. Interestingly, late melatonin treatment (10 mg/kg), starting once the alterations mentioned above were established (from day 7 to day 28), reduced oxidative stress, neuroinflammation, tau hyperphosphorylation, and caspase‐3 activation; these observations correlated with restoration of the autophagy flux and memory improvement. This study highlights the importance of autophagic dysregulation in tauopathy and how administration of pharmacological doses of melatonin, once tauopathy is initiated, can restore the autophagy flux, reduce proteinopathy, and prevent cognitive decline. We therefore propose exogenous melatonin supplementation or the development of melatonin derivatives to improve autophagy flux for the treatment of proteinopathies like AD. 相似文献
104.
105.
106.
107.
108.
目的观察飞秒激光小切口角膜基质透镜取出术(SMILE)术后超早期患者视觉质量变化,探讨其变化发生的可能原因。方法选取中低度近视患者23例46眼行SMILE术,术前及术后24 h超早期行主观视觉质量问卷,测量最佳矫正视力的全程视力(远视力5 m,中视力60 cm,近视力33 cm)、对比敏感度(CS)、眩光敏感度(GS)及集合近点(NPC)和调节幅度(AA)。结果视觉质量主观问卷显示术后超早期主观视觉质量较术前下降(P=0.001)。术后裸眼视力(UCVA)明显提高(P=0.0001)。术前与术后最佳矫正视力(BCVA)中远视力没有变化(P=0.096),而中视力和近视力均较术前下降(P=0.039,0.003)。术后CS、GS降低(PCS=0.0001,PGS=0.04),NPC、AA较术前无明显变化(P=0.68,0.13)。结论SMILE术后超早期患者可获得预期理想远视力,但中、近视力尚未恢复。超早期中出现的异常视觉质量改变可能与对比敏感度和眩光敏感度的改变有关。 相似文献
109.
Very preterm children are at increased risk of reduced processing speed at 5 years of age,predicted by typical complications of prematurity and prenatal smoking 下载免费PDF全文
110.
Melatonin reduces oxidative stress and improves vascular function in pulmonary hypertensive newborn sheep 下载免费PDF全文
Flavio Torres Alejandro González‐Candia Camilo Montt Germán Ebensperger Magdalena Chubretovic María Serón‐Ferré Roberto V. Reyes Aníbal J. Llanos Emilio A. Herrera 《Journal of pineal research》2015,58(3):362-373
Pulmonary hypertension of the newborn (PHN) constitutes a critical condition with severe cardiovascular and neurological consequences. One of its main causes is hypoxia during gestation, and thus, it is a public health concern in populations living above 2500 m. Although some mechanisms are recognized, the pathophysiological facts that lead to PHN are not fully understood, which explains the lack of an effective treatment. Oxidative stress is one of the proposed mechanisms inducing pulmonary vascular dysfunction and PHN. Therefore, we assessed whether melatonin, a potent antioxidant, improves pulmonary vascular function. Twelve newborn sheep were gestated, born, and raised at 3600 meters. At 3 days old, lambs were catheterized and daily cardiovascular measurements were recorded. Lambs were divided into two groups, one received daily vehicle as control and another received daily melatonin (1 mg/kg/d), for 8 days. At 11 days old, lung tissue and small pulmonary arteries (SPA) were collected. Melatonin decreased pulmonary pressure and resistance for the first 3 days of treatment. Further, melatonin significantly improved the vasodilator function of SPA, enhancing the endothelial‐ and muscular‐dependent pathways. This was associated with an enhanced nitric oxide‐dependent and nitric oxide independent vasodilator components and with increased nitric oxide bioavailability in lung tissue. Further, melatonin reduced the pulmonary oxidative stress markers and increased enzymatic and nonenzymatic antioxidant capacity. Finally, these effects were associated with an increase of lumen diameter and a mild decrease in the wall of the pulmonary arteries. These outcomes support the use of melatonin as an adjuvant in the treatment for PHN. 相似文献